Acute Sinusitis, Causes, Symptoms, Treatment

Acute Sinusitis

Acute Sinusitis/Sinusitis is inflammation of the sinus or nasal passage. Chronic sinusitis is chronic inflammation of the sinus or nasal passages occurring for more than 12 weeks at a time. Recurrent sinusitis is defined as greater than four episodes of sinusitis within a one-year period. The evaluation and management of acute and chronic sinusitis are similar. Chronic sinusitis may present as 1) chronic sinusitis without nasal polyps 2) chronic sinusitis with nasal polyps and 3) allergic fungal rhinosinusitis. 

Rhinitis is the inflammation of the nasal mucosa. It can be defined as symptoms of nasal irritation, sneezing, rhinorrhoea and nasal blockage lasting for at least 1 h a day on most days. The term “sinusitis” refers to inflammation of the mucosa of the paranasal sinuses, regardless of the cause. As the understanding of the pathophysiology of the nasal mucosa has evolved, the differentiation between rhinitis and sinusitis has become less apparent.

Pathophysiology

Pathogenesis of rhinosinusitis is as a result of dysfunction of sinus ostia (narrowing), the ciliary apparatus, and viscous sinus secretions. Viral upper respiratory infection or allergens result in mucosal edema to lead to narrowing of the sinus ostia causing direct mechanical obstruction. When there is an obstruction of the sinus ostium, there is a transient increase in pressure within the sinus cavity. As air is depleted in this close space, the pressure in the sinus becomes negative relative to atmospheric air pressure. This negative pressure possibly allows nasal bacteria into sinuses during sniffing or nose blowing. When the sinus ostium is obstructed, secretion of mucous by mucosa continues, resulting in fluid accumulation in the sinus. During viral colds other inflammation of nasal ostia and mucosal membranes, both the structure and the function of the mucociliary apparatus are impaired. The quality and characteristics of sinus secretions also determine the pathogenesis of sinusitis. Cilia can beat only in a fluid. The mucous blanket in the respiratory tract is made up of two layers. The sol phase is a thin, low-viscosity layer that surrounds the shaft of the cilia and allows the cilia to beat freely. The gel phase is a more viscous layer and rides on the sol phase. Alterations in the mucous layer, which occur in the presence of inflammatory debris, as in infected sinus, may further impair ciliary movement. Similarly, mucociliary dysfunction may occur due to frequent irrigation of the nasal cavity.

Acute Sinusitis

Sinusitis Types

By Severity

  • Acute rhinosinusitis – Sudden onset, lasting less than 4 weeks with complete resolution. Causesd by Haemophilus influenzae, Streptococcus pneumoniae (rarely: anaerobes, Gram negative bacteria, Staphylococcus aureusMoraxella catarrhalisStreptococcus pyogenes)
  • Subacute rhinosinusitis – A continuum of acute rhinosinusitis but less than 12 weeks. Four or more full episodes of acute sinusitis that occur within one year. Caused by Anaerobes, Gram-negative bacteria, S aureus (rarely, fungal). An infection that lasts between four and 12 weeks, and represents a transition between acute and chronic infection
  • Recurrent acute rhinosinusitis – Four or more episodes of acute, lasting at least 7 days each, in any 1-year period.
  • Chronic rhinosinusitis – Signs of symptoms persist 12 weeks or longer.
  • Acute exacerbation of chronic sinusitis – When the signs and symptoms of chronic sinusitis exacerbate, but return to baseline after treatment

By Location

There are four paired paranasal sinuses, the frontal, ethmoidal, maxillary, and sphenoidal sinuses. The ethmoidal sinuses are further subdivided into anterior and posterior ethmoid sinuses, the division of which is defined as the basal lamella of the middle nasal concha. In addition to the severity of disease, discussed below, sinusitis can be classified by the sinus cavity which it affects:

  • Maxillary – can cause pain or pressure in the maxillary (cheek) area (e.g., toothache,[rx] or headache) (J01.0/J32.0)
  • Frontal – can cause pain or pressure in the frontal sinus cavity (located above the eyes), headache, particularly in the forehead (J01.1/J32.1)
  • Ethmoidal – can cause pain or pressure pain between/behind the eyes, the sides of the upper part of the nose (the medial canthi), and headaches (J01.2/J32.2)[rx]
  • Sphenoidal – can cause pain or pressure behind the eyes, but is often felt in the top of the head, over the mastoid processes, or the back of the head.[rx]

Acute Sinusitis

Sinusitis Causes

  • Abnormality of the osteomeatal complex, Septal deviation, Concha bullosa, Hypertrophic middle turbinates
  • smoker (a second-hand smoker has a higher risk of CRS with current and past exposure)
  • asthma, especially in the presence of CRS with nasal polyps (CRSwNP)
  • allergies, chronic bronchitis and emphysema
  • Viral infection
  • Allergic and non-allergic rhinitis
  • Cigarette smoking
  • Diabetes mellitus
  • Swimming, diving, high altitude climbing
  • Dental infections and procedures
  • Cystic fibrosis
  • Neoplasia
  • Mechanical ventilation
  • Use of nasal tubes, such as nasogastric feeding tubes
  • Samter’s triad (aspirin sensitivity, rhinitis, asthma)
  • Sarcoidosis
  • Wegener’s granulomatosis
  • Immune deficiency
  • Sinus surgery
  • Immotile cilia syndrome
  • Anatomical variations
  • ARS
  • chronic rhinitis
  • gastroesophageal reflux disease
  • sleep apnoea
  • adenotonsillitis

 Symptoms of Sinusitis

  • Headache due to pressure in partially or completely blocked sinuses. The pain may increase when the person bends down.
  • Facial tenderness and/or swelling when facial areas over sinus areas are touched.
  • Pressure or pain due to mucus pressing on sinus tissue or inflammation of sinuses.
  • Fever due to inflammation of sinus tissues and infection.
  • A cloudy, discolored nasal drainage is often seen in bacterial sinus infections.
  • Congestion is a feeling of nasal stuffiness, and occurs with both infectious and non-infectious sinusitis.
  • Post nasal drip is mucus overproduction from sinusitis that flows to the throat and irritates throat tissue.
  • Sore throat is inflammation of throat tissue by post nasal drip.
  • Cough is a response to post nasal drip and body’s attempt to clear out throat tissue irritants.
  • Tooth pain caused by pressure on surrounding nerves and tissues
  • Ear pain caused by pressure on surrounding nerves and tissues
  • Eye pain caused by pressure on surrounding nerves and tissues
  • Fatigue due to fever, immune response and/or coughing
  • Bad breath usually is due to bacterial infections
  • Itching/sneezing – In noninfectious sinusitis, other associated allergy symptoms of itching eyes and sneezing may be common, but may include some of the symptoms listed above for infectious sinusitis.
  • Nasal drainage usually is clear or whitish-colored in people with noninfectious sinusitis.
  • Ulceration can occur with rare fulminant fungal infections with sharply defined edges and a black, necrotic center in the nasal area. Some fungal infections cause dark, black-appearing exudates. This requires immediate medical evaluation.
  • Multiple chronic (over one to three months) symptoms usually are a sign of subacute or chronic sinusitis
  •  Nasal obstruction or congestion
  • Hyposmia (reduced sense of smell)
  • Facial pressure, pain, tenderness
  • Rhinorrhoea (anterior or postnasal)
  • Fever or malaise (acute infection)
  • Toothache (upper teeth)

Acute Sinusitis

Sinusitis Diagnosis

Chronic sinusitis is diagnosed when at least two of the following four symptoms are present and occur for more than 12 weeks:

  • (1) Purulent drainage,
  • (2) Facial and/or dental pain,
  • (3) Nasal obstruction,
  • (4) Hyposmia).

The Infectious Disease Society of America (IDSA) defines sinusitis as two of the following major clinical symptoms: purulent nasal discharge, nasal congestion or obstruction, facial congestion or fullness, facial pain or pressure, hyposmia, anosmia. Alternatively, ISDA defines sinusitis as one of the aforementioned major symptoms plus two or more minor criteria such as a headache, ear pain, pressure, or fullness, halitosis or bad breath, dental pain, cough, or fatigue.

Physical examination

  • ARS – An anterior rhinoscopy should be performed as part of the clinical assessment of suspected ARS in a primary care setting. It may reveal findings such as mucosal oedema, nasal inflammation, purulent nasal discharge, polyps and/or anatomical abnormalities.

  • CRS – Anterior rhinoscopy has a limited value in diagnosing CRS. Diagnosis of CRS requires a nasal endoscopy by an otorhinolaryngology (ORL) surgeon, which provides better visualisation of nasal pathologies, including anatomical variations, mucosal inflammation, polyps and nasal discharge.

Laboratory

A nasal swab should not be performed in the case of RS in the primary care setting due to its low predictive value in diagnosing ABRS and CRS. An endoscopically-directed middle meatal culture by otorhinolaryngologists can obtain a specimen for culture and susceptibility tests in unresolved ABRS (no response to antibiotics after 72 hours).

The organisms most commonly associated with ABRS are

  • Streptococcus pneumoniae

  • Haemophilus influenzae

  • Moraxella catarrhalis (more commonly in children)

Anaerobic organisms are predominant in ARS with dental origin.

In CRS, the most commonly involved organisms are:

  • Staphylococcus aureus

  • Enterobacteriaceae spp

  • Pseudomonas spp

  • Radiology

Plain radiography is not recommended in the management of RS.

A computed tomography (CT) scan is the gold standard for radiographic evaluation of the paranasal sinuses. A CT scan of the paranasal sinuses should be considered in the ORL setting when

  • medical therapy fails

  • surgery is planned

  • complications are suspected

CRS, with or without nasal polyps in adults is defined as:

  • inflammation of the nose and the paranasal sinuses characterized by two or more symptoms, one of which should be either nasal blockage/obstruction/congestion or nasal discharge (anterior/posterior nasal drip) ± facial pain/pressure ± reduction or loss of smell for ≥ 12 weeks.

This should be supported by demonstrable disease with endoscopic signs of:

  • nasal polyps, and/or mucopurulent discharge primarily from middle meatus and/or edema/mucosal obstruction primarily in middle meatus.

and/or

  • computed tomography (CT) changes: mucosal changes within the ostiomeatal complex and/or sinuses.

Nasal cytology

  • Sinus puncture (maxillary or frontal sinus) remains the gold standard for obtaining sinus culture material, with many studies showing little correlation between nasal swab and sinus culture., Nasal cytology (Hansel, Wright of Gram stain) could be performed in cases of acute rhinosinusitis. Presence of neutrophils and bacteria suggests bacterial rhinosinusitis.

Radiology

  • Radiology has traditionally been used as an investigative tool to diagnose acute rhinosinusitis. This includes plain sinus radiographs and computed tomography (CT) scans of the paranasal sinuses.

X ray

  • Plain sinus radiographs are commonly used as a first‐line investigation for sinusitis. They are indicated in cases of acute rhinosinusitis only if symptoms persist despite adequate treatment. Sinus radiographs are not performed in children <3 years of age due to undeveloped sinuses and high false positive opacification rat.

Acute Sinusitis

Treatment of Sinusitis

There is no consensus on an approach to the management of chronic sinusitis. The treatment should focus on modulating triggers, reducing inflammation, and eradicating the infection.

Trigger Reduction

  • Allergy testing can help identify environmental triggers that patients should avoid.

[dropshadowbox align=”none” effect=”lifted-both” width=”auto” height=”” background_color=”#ffffff” border_width=”3″ border_color=”#dddddd” ]

Medication

  • Antibiotics – Use empirically and based on community patterns of resistance. Ten to 14 days of amoxicillin or amoxicillin-clavulanate is first-line treatment.Amoxicillin, cephalosporins and macrolides have been studied extensively.,. Amoxicillin–clavulanate compared to antibiotics in the cephalosporin class was found to be 41% more effective in reducing clinical failure within 10–25 days after treatment initiation. In some communities, amoxicillin effectiveness is less than 70%. Trimethoprim-sulfamethoxazole well for some, but there is a higher rate of resistance.
  • Failure of symptoms – to resolve after 7 days of therapy should prompt one to switch to a broader spectrum agent, such as ten to fourteen days of augmentin, cefuroxime axetil, other second or third-generation cephalosporins, clindamycin alone or along with ciprofloxacin, sulfamethoxazole, a macrolide, or one of the fluoroquinolones.
  • Metronidazole – may be added to any one of these agents to increase anaerobic coverage. For chronic sinusitis, antibiotics should cover S. aureus and be effective against the higher incidence of beta-lactamase producing organisms that are common in chronic disease. If the patient is not improving after 5 to 7 days, add metronidazole or clindamycin. Treat for 3 to 6 weeks.
  • Analgesics – paracetamol or non-steroidal anti-inflammatory drugs may provide symptomatic relief in both viral and bacterial infections of the upper respiratory passages in RS.
  • Mucolytics and antiviral agents –  There is no evidence to support the use of these agents in RS.
  • Nasal steroids – should be used with or without nasal saline irrigation. The treatment should last at least eight to 12 weeks with proper usage.
  • Nasal saline – irrigation is inferior to nasal steroids. However,  nasal saline irrigation can serve as a useful adjunct. High volume nasal saline irrigation was found to be more effective than low-volume nasal spray techniques.
  • Antihistamines – should only be used if an allergic component is suspected.
  • Anti-fungal – empiric therapy should not be given.
  • Oral steroids – can be used. However, their use is not routinely indicated. Comments regarding their use are given below.  Should oral steroids be used, physicians should engage in shared decision-making with patients.

[/dropshadowbox]

Decongestant

  • An oral decongestant will help reduce inflammation and secretion from the nasal, sinus, and respiratory tract mucosa thus assisting symptomatic relief. This may also assist in keeping the nasal ostia open and resulting in a reduction of sinus pressure. An oral antihistamine may be helpful if suspected sinusitis is as a result of allergic rhinitis. Oral steroids are not recommended for symptomatic relief.

Topical Intranasal Therapy

  • Nasal irrigation with saline is an effective symptomatic relief as a result of viral or allergic rhinosinusitis. It should be stressed that prolonged and frequent nasal irrigation of nasal cavity may alter the mucociliary apparatus to result into increase in symptoms of sinus congestion.
  • A topical spray of fluticasone may help reduce inflammation and reduce the flaring up. Another topic spray such as oxymetazoline or phenylephrine nasal may help reducing congestion. Patients should be cautioned of rebound congestion following these decongestant sprays and limit the spray to 3 days.

Topical Anticholinergics

  • Parasympathetic fibres are distributed widely in the nasal glands and blood vessels. Parasympathetic stimulation causes a watery secretion mediated by acetylcholine and vasodilatation of blood vessels serving the glands. Anticholinergic drugs can block the muscarinic receptors of the sero‐mucinous glands. Topical anticholinergics, such as ipratropium bromide nasal spray, are primarily used to control symptom of rhinorrhoea.

Antihistamines

  • No clinical studies support the use of antihistamines for treatment of acute rhinosinusitis. They may probably be beneficial due to their anti‐inflammatory effect. On the other hand, anticholinergic effects of first generation antihistamines could impair clearance by thickening mucus. Second generation antihistamines are not recommended for acute rhinosinusitis as they do not have anticholinergic effect.

Mucolytic Agents

  • Guaiphensin is a commonly used mucolytic agent. It is usually used in combination with a decongestant preparation. Although it is prescribed to thin the mucous secretions and improve drainage, studies comparing the effects of guaiphensin and placebo on nasal mucociliary clearance and ciliary beat frequency have failed to show any measurable effect.

Nasal Saline Spray/Saline Irrigation

  • Saline sprays have been shown to reduce symptoms of rhinitis. Daily hypertonic saline nasal irrigation has been shown to result in improved sinus‐related quality of life, decreased symptoms and decreased medication use in patients with frequent sinusitis. There has been no reported serious adverse effect with saline irrigation.

Topical corticosteroids

  • Most studies of intranasal steroid use in acute rhinosinusitis have not shown an effect on clinical outcome. The use of intranasal beclomethasone in the treatment of the common cold neither reduced symptoms caused by inflammation, nor shortened the recovery time.
  • However, mometasone furoate nasal spray, used as an adjunctive treatment with an oral antibiotic, has been shown to be significantly more effective in reducing the symptoms of acute rhinosinusitis than antibiotic treatment alone., Fluticasone propionate treatment tends to prevent paranasal sinusitis, especially in rhinovirus‐positive subjects, but does not have any notable effects on the symptoms or recovery time of the common cold.

Vitamin C, Zinc salt Lozenges

  • There is insufficient evidence to recommend the use of vitamin C or zinc salt lozenges in patients with acute bacterial rhinosinusitis. Using the outcome of cold symptoms after 7 days, a meta‐ analysis of eight clinical trials of zinc salt lozenge for the treatment of common cold did not find a significant benefit. In contrast, clinical trials showed that zinc effectively and significantly shortened the duration of the common cold when it was administered within 24 h of the onset of symptoms. Vitamin C may have a small role in preventing the common cold, especially in persons exposed to brief periods of severe physical activity or cold environments,, but has no apparent effect on the duration or severity of symptoms.

Nasal Polyps

  • Chronic sinusitis with polyps should be treated with topical nasal steroids. If severe or unresponsive to therapy after 12 weeks, a short-course of oral steroids can be considered.
  • Leukotriene antagonists can be considered.

Other Emerging Options

Many adjunctive agents have been utilized to control CRS including antimycotics, anti-IgE, anti-IL5, antihistamine, aspirin desensitization, bacterial lysates, capsaicin,complementary and alternative medicine, decongestants, furosemide, immunosuppressants, leukotriene antagonists,nasal irrigation, mucolytic agents,phototherapy, probiotics, and proton pump inhibitors (PPIs). There was limited evidence on the effect of these options. We will focus this topic only on medications with positive effects.

Anti-IgE

Several investigators found that CRSwNP patients have higher IgE in polyps and serum than controls. One randomized controlled trial used omalizumab for 6 months compared with placebo in CRS patients. They found improvement of sinus opacification in CT-scans and the SNOT-20, but there was not a significant difference.

Anti-IL-5

IL-5 is the key mediator in eosinophil activation. Sejima et al found that patients with CRSwNP had higher levels of IL-5 compared with patients with CRSsNP. There were some small Phase II randomized controlled trials that found a positive effect of reslizumab and mepolizumab in decreasing polyp size. These drugs may have a possible role in treatment of CRSwNP in the future.

Bacterial Lysates

The mechanisms of bacterial lysates are hypothesized to enhance the process of postnatal maturation of T helper (Th)1 function and dendritic cells., The efficacy of bacterial lysates (Broncho-Vaxom, OM Pharma, Geneva, Switzerland) was investigated compared with placebo. They found a significant improvement in symptoms including headache, purulent discharge, cough, and expectoration in the bacterial lysates group.

Capsaicin

The calcitonin gene-related peptide (CGRP) is a vasodilator agent present in sensory nerves and may play a major role in the vascular component of neurogenic inflammation. Repeated intranasal applications of capsaicin induced a reduction in both concentration of CGRP-like immunoreactivity and rhinitis symptoms. One randomized controlled trial found that patients treated with capsaicin showed a significant smaller staging of their nasal polyposis compared with the control group.

Complementary and Alternative Medicine

The complementary and alternative medicines used to treat CRS include herbal medicine, vitamins, homeopathy, acupuncture, massage, reflexology, yoga, and chiropractics. Richstein and Mann compared the herbal preparation (European elder, common sorrel, cowslip, European vervain and gentian) with placebo, and found improvement of the overall clinical status and possible improvement on the radiological findings in the herbal preparation group (12/16 patients) and placebo group (6/15 patients). Another study reported a significant effect on nasal mucosa inflammation reduction and overall rating in the herbal preparation group, but no significant difference in other symptoms including nasal mucosa edema, nasal discharge, and breathing difficulties.

Furosemide

Furosemide could induce cell shrinkage by mediating the net influx of osmotically active ions and hypothetically have immunomodulatory and anti-inflammatory effects in hyperactive airway disease., One randomized controlled trial compared topical furosemide versus oral methylprednisolone for 7 days preoperatively. Furosemide could significantly reduce the subjective and endoscopic score when compared to baseline but was not significant when compared to oral methylprednisolone.

Nasal irrigation

Nasal irrigation has been introduced as an adjunctive treatment. It facilitates mechanical removal of mucus, infective pathogens, and inflammatory mediators and promotes ciliary beat frequency. Freeman et alstudied the efficacy of saline irrigation post-endoscopic sinus surgery. At 3 weeks postoperatively, the outcomes showed a significant improvement of discharge in the saline douching group compared with no treatment (P = 0.046). However, at 3 months postoperatively, there was only a minimal difference with crusting (P = 0.18) and edema (P = 0.32), and no difference with adhesions, discharge, and polyps.Khianey et al also found a small clinical benefit of the nasal saline irrigation with minimal side effects.

Mucolytic Agents

Some studies used mucolytic agents as an adjunctive drug for treating patients with tenacious mucus. Majima et al assessed the efficacy of S-carboxymethylcysteine in CRS patients without nasal polyps or with small nasal polyps. After 12 weeks of treatment, the nasal discharge and post-nasal discharge were significantly improved in the S-carboxymethylcysteine group (P = 0.008 and P = 0.002, respectively). However, the SNOT-20 and CT scores were not significantly different between groups.

PPIs

Esophageal reflux was considered a potential cause of CRS. Using PPIs to decrease acid reflux may reduce sinonasal mucosal damage. An uncontrolled trial evaluating PPIs in CRS patients reported improvement in sinus symptoms (nasal congestion, nasal drainage, sinus pressure, facial headache, malaise) and global satisfaction (25%–89% and 91%, respectively).

Phototherapy

Near-infrared laser illumination (NILI), with or without photo-activated (PA) agents, has bactericidal and wound healing promoting effects which may have a potential role in managing CRS. Krespi et alconducted a prospective randomized study with 23 symptomatic post-surgical CRS patients comparing NILI versus NILI with PA. Both therapy arms demonstrated clinical efficacy. The SNOT-20 score change was 0.9 for the NILI group and 0.8 for the NILI with PA group (P < 0.05).

Surgery

  • Functional endoscopic sinus surgery can be considered for patients who fail medical management. In more complicated cases, it can serve as an adjunct to medical management. The goal of this surgery is to relieve obstructions, restore drainage and mucociliary clearance, and to ventilate the sinuses.
  • Interventions such as balloon sinuplasty are not recommended for recurrent sinusitis and should be reserved for patients with chronic sinusitis refractory to medical management.

Antral Washout

Antral washout was the mainstay surgical procedure in the past, especially in patients who failed to respond to medical treatment. Currently its use is limited only to severe cases of acute rhinosinusitis that result in abscess formation within the paranasal sinuses. Sinus puncture and irrigation techniques allow removal of thick purulent sinus secretions.

External Frontoethmoidectomy

An external approach to the ethmoidal sinuses in acute rhinosinusitis is limited to cases of complications of acute ethmoiditis such as orbital cellulites/abscess. It allows decompression and drainage of the involved sinuses, including subperiosteal and retro‐orbital abscess. Nowadays, it can be accompanied endoscopically in most patients.

Frontal Sinus Trephination

The traditional approach to acute frontal sinusitis (empyema) that fails to respond to conservative treatment is to trephine the sinus, but management of acute frontal sinusitis with restoration of integrity of the nasal frontal duct using endoscopic sinus surgical techniques is an ideal alternative.

Functional Endoscopic Sinus Surgery

The introduction of endoscopes in sinus surgery has brought a revolution in the approach to surgery of the sinuses through the nasal cavity. It allows ventilation and drainage of the inflamed/infected sinuses and restoration of their mucociliary clearance. The role of functional endoscopic sinus surgery in acute rhinosinusitis is limited mainly to management of acute complications; however, it is often not the first choice for managing complications as there would be a greater tendency to bleeding. It has proven very effective in managing recurrent acute or chronic sinusitis.,

Complications 

  • Laryngitis
  • Dacryocystitis
  • Orbital cellulitis/abscess
  • Cavernous sinus thrombosis
  • Meningitis, subdural abscess, brain abscess
  • Frontal bone osteomyelitis

Orbital

  • Preseptal cellulitis
  • Orbital cellulitis
  • Orbital abscess
  • Osteomyelitis
  • Subperiosteal orbital abscess

Intracranial

  • Subdural empyema
  • Epidural empyema
  • Meningitis
  • Brain abscess
  • Cortical thrombophlebitis
  • Cavernous/sagittal sinus thrombosis

Prevention

  • Bathe your nasal passages dailyRun water gently into the nasal passages to help clear excess mucus and moisten membranes. During the day, use nasal saline spray to moisten nasal passages.
  • Drink lots of water Good hydration helps keep the mucus thin and loose. Have a bottle of water at your desk at work, or put a glass near the kitchen sink to remind you to drink water throughout the day.
  • Inhale steam Linger in a hot shower. Or bring water to a boil, and pour it into a pan; place a towel over your head, and carefully bend over the pan to inhale the steam. To avoid burns, keep your distance at first and move in gradually to a comfortable zone.
  • Avoid dry environments  A humidifier in your home (in particular, by your bed) and where you work can help prevent nasal passages from drying out. Keep humidifiers clean and free of bacteria and mold.
  • Sleep with your head elevated  Mucus pools in your sinuses at night when your head is down, so have your head propped up with pillows or a wedge during sleep.
  • Be nice to your nose Blow your nose gently, one nostril at a time. Forceful blowing can irritate the nasal passages and propel bacteria-laden mucus back up into your sinuses.
  • Avoid antihistamines unless prescribed  Antihistamines make mucus thick and hard to drain. But if your sinusitis is triggered by allergies, your clinician may still want you to take an antihistamine along with other medications.
  • Be careful with decongestants  Tablets containing pseudoephedrine act on blood vessels to shrink membranes and keep nasal passages open. Nasal sprays containing phenylephrine or oxymetazoline also work well — and quickly. But using topical nasal decongestants for more than a day or two runs the risk of setting off a spiral of dependency as a result of rebound — increased swelling after the medication wears off.

References

Acute Sinusitis